Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lung

Rationale for the use of alternating non-cross-resistant chemotherapy.

1982 • 545 citations

Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.

1979 • 179 citations

Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis.

1980 • 175 citations

Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.

1982 • 131 citations

Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo.

1972 • 115 citations

Treatment of bronchogenic carcinoma

1977 • 113 citations

Long-term results in combined-modality treatment of small cell carcinoma of the lung.

1978 • 112 citations

Small cell carcinoma of the lung

1982 • 73 citations

Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung.

1983 • 66 citations

Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.

1973 • 64 citations

Long-term survivorship in small-cell anaplastic lung carcinoma.

1979 • 36 citations

Phase III study of CCNU, cyclophosphamide, adriamycin, vincristine, and VP-16 in small-cell carcinoma of the lung

1982 • 36 citations

Evaluation of alternating chemotherapy and sites and extent of disease in extensive small cell lung cancer

1981 • 26 citations

Alternating non-cross-resistant combination chemotherapy for small cell anaplastic carcinoma of the lung

1982 • 24 citations

Chemotherapy of small cell carcinoma of the lung: Comparison of a cyclic alternative combination with simultaneous combinations of four and seven agents

1981 • 20 citations

Progress in the chemotherapy of small cell carcinoma of the lung

1981 • 19 citations

A Controlled Clinical Trial Testing Two Potentially Non-Cross-Resistant Chemotherapeutic Regimens in Small-Cell Carcinoma of the Lung

1981 • 14 citations

Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.

1977 • 14 citations

Phase II study of procarbazine in small cell carcinoma of the lung.

1982 • 13 citations

Alternating non-cross-resistant drug combinations in the treatment of metastatic small-cell carcinoma of the lung.

1981 • 13 citations

Cyclophosphamide, adriamycin and 5-fluorouracil (CAF) alternating with a cycle-active regimen in metastatic breast cancer: A randomized southeastern cancer study group trial

1981 • 9 citations